iPacemaker AI Follow-up

ืจื›ื™ืฉื•ืช ืžืชื•ืš ื”ืืคืœื™ืงืฆื™ื”
+1Kโ€
ื”ื•ืจื“ื•ืช
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
ื›ื•ืœื
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš

ืžื™ื“ืข ืขืœ ื”ืืคืœื™ืงืฆื™ื” ื”ื–ื•

ืžืขืงื‘ iPacemaker: ื™ื“ืข ื‘ืงืฆื•ืช ืืฆื‘ืขื•ืชื™ืš!

ื”ืื ืืชื” ืื™ืฉ ืžืงืฆื•ืข ื‘ืชื—ื•ื ื”ื‘ืจื™ืื•ืช, ืขื•ื‘ื“ ืฉืœ ื—ื‘ืจื” ืจืคื•ืื™ืช, ืื• ืžื™ืฉื”ื• ืฉืžืชืขื ื™ื™ืŸ ื‘ืžื›ืฉื™ืจื™ ืœื‘ ืžื•ืฉืชืœื™ื? ืืœ ืชื—ืคืฉ ืขื•ื“! iPacemaker Follow-up ื”ื™ื ื”ืืคืœื™ืงืฆื™ื” ื”ืื•ืœื˜ื™ืžื˜ื™ื‘ื™ืช ืฉืœืš ืœืฉืœื™ื˜ื” ื‘ื ื™ื”ื•ืœ ื”ืงืœื™ื ื™ ืฉืœ ืงื•ืฆื‘ื™ ืœื‘ ื•ื“ืคื™ื‘ืจื™ืœื˜ื•ืจื™ื ืžื•ืฉืชืœื™ื. ืžื•ืคืขืœ ืขืœ ื™ื“ื™ ื‘ื™ื ื” ืžืœืื›ื•ืชื™ืช ืžืชืงื“ืžืช, ืืคืœื™ืงืฆื™ื” ื–ื• ืžืฉืคืจืช ืืช ื”ื”ื‘ื ื” ืฉืœืš ืœื’ื‘ื™ ืžื•ืฉื’ื™ื ื•ื˜ื›ื ื•ืœื•ื’ื™ื•ืช ื‘ืชื—ื•ื. ืขื ืœืžืขืœื” ืž-150 ืžืงืจื™ื ืงืœื™ื ื™ื™ื ืืžื™ืชื™ื™ื, ื”ื•ื ืžืกืคืง ืชืžื™ื›ื” ืžืงื™ืคื” ื‘ืืžืฆืขื•ืช ืžื“ืจื™ื›ื™ื, ืคืชืจื•ืŸ ื‘ืขื™ื•ืช, ืชื›ื ื•ืช ื•ืงื˜ืขื™ ืžืขืงื‘.

ืฉื™ืžื• ืœื‘: ื ื“ืจืฉ ืžื ื•ื™ ื›ื“ื™ ืœื’ืฉืช ืœืชื•ื›ืŸ ื”ืžืœื.

ืžืงืจื™ื ืงืœื™ื ื™ื™ื
ืฆืœื•ืœ ืœืžืงืจื™ื ืงืœื™ื ื™ื™ื ืืžื™ืชื™ื™ื ืขื ื›ืœ ื”ืชื™ืขื•ื“ ื”ืงืฉื•ืจ (ืจืฆื•ืขื•ืช ืžืชื›ื ืช, ื.ืง.ื’, ืจื ื˜ื’ืŸ ื•ื›ื•') ื›ื“ื™ ืœืœืžื•ื“ ืขืœ ื”ืคืจืขื•ืช ืงืฆื‘ ืœื‘ ื•ื”ื”ืฉืคืขื” ืžืฆื™ืœืช ื”ื—ื™ื™ื ืฉืœ ืžื›ืฉื™ืจื™ ืœื‘.

ื—ึดื™ื“ื•ึนืŸ
ื‘ื“ื•ืง ืืช ื”ื™ื“ืข ืฉืœืš ื‘ื ื™ื”ื•ืœ ืงืฆื‘ ืœื‘ ืขื 150 ืฉืืœื•ืช ืžืกื•ื•ื’ื•ืช ืœืคื™ ื ื•ืฉืื™ื (CRT-D, ICD, IPG), ืจืžื•ืช ืงื•ืฉื™ ื•ื™ืฆืจื ื™ื ืฉื•ื ื™ื (Abbott, Biotronik, Boston Scientific, Medtronic).

ืคืชืจื•ืŸ ื‘ืขื™ื•ืช
ื”ื‘ืŸ ืืช ื”ืกื™ื‘ื•ืช ื•ื”ืคืชืจื•ื ื•ืช ืœื‘ืขื™ื•ืช ื ืคื•ืฆื•ืช (ื—ื™ื™ืฉืช ื™ืชืจ, ื—ื•ืกืจ ื—ื™ืฉื”, ื›ืฉืœ ืœื›ื™ื“ื”, ื›ืฉืœ ื‘ืคืœื˜, ืชืงืœื•ืช ืคืกืื•ื“ื• ื”ืงืฉื•ืจื•ืช ืœืงืฆื‘), ืžื•ืžื—ืฉื™ื ืขื ื“ื•ื’ืžืื•ืช ืžืžืงืจื™ื ืงืœื™ื ื™ื™ื ืืžื™ืชื™ื™ื.

ืชึดื›ื ื•ึผืช
ื—ืงื•ืจ ืชื›ื ื•ืช ืžื›ืฉื™ืจื™ื ื”ืžื•ืชืืžื™ื ืœืžืฆื‘ื™ื ื”ืงืœื™ื ื™ื™ื ืฉืœ ื”ืžื˜ื•ืคืœื™ื, ื‘ื”ื ื—ื™ื™ืช ื”ืคืจืกื•ืžื™ื ื”ืžื“ืขื™ื™ื ื”ืื—ืจื•ื ื™ื.

ืžืขืงื‘
ืœืžื“ ืœื ื”ืœ ืžืขืงื‘ื™ื ืฉื’ืจืชื™ื™ื ื‘ืงืœื™ื ื™ืงื”, ืœืชืคื•ืก ืขืจื›ื™ ื”ืชื™ื™ื—ืกื•ืช ื•ืœืขืงื•ื‘ ืื—ืจ ื”ื“ืจื›ื•ืช ืžืคื•ืจื˜ื•ืช ื”ืžื ื—ื•ืช ืื•ืชืš ืฉืœื‘ ืื—ืจ ืฉืœื‘ ื‘ืชื”ืœื™ืš ื”ืžืขืงื‘.

ื”ื“ืจื›ื•ืช
ืฆืคื• ื‘ืขืฉืจื•ืช ื”ื“ืจื›ื•ืช ืขืœ ื ื™ื”ื•ืœ ืžื›ืฉื™ืจื™ื (ืคืชืจื•ืŸ ืชืงืœื•ืช, ืชื›ื ื•ืช, ืžืขืงื‘) ืžืžื•ืชื’ื™ื ืฉื•ื ื™ื ื‘ืืžืฆืขื•ืช ืžืชื›ื ืชื™ื ืฉื•ื ื™ื.

ื ืฆืœ ืืช ืžืœื•ื ื”ืคื•ื˜ื ืฆื™ืืœ ืฉืœ ื”ืžื•ืžื—ื™ื•ืช ืฉืœืš ืขื iPacemaker Follow-up. ืžื•ืคืขืœ ืขืœ ื™ื“ื™ ื‘ื™ื ื” ืžืœืื›ื•ืชื™ืช, ืืคืœื™ืงืฆื™ื” ื–ื• ื”ื™ื ื”ืžืฉืื‘ ื”ืžืงื™ืฃ ืฉืœืš ืœื”ื‘ื ื” ื•ื ื™ื”ื•ืœ ืฉืœ ืžื›ืฉื™ืจื™ ืœื‘. ื”ื™ืจืฉื ืขื›ืฉื™ื• ื›ื“ื™ ืœืงื‘ืœ ื’ื™ืฉื” ืœื›ืœ ื”ืžืฉืื‘ื™ื ื”ื™ืงืจื™ื ื”ืืœื”!
ืขื“ื›ื•ืŸ ืื—ืจื•ืŸ ื‘ืชืืจื™ืš
31 ื‘ืื•ืงืณ 2025

ืื‘ื˜ื—ืช ื ืชื•ื ื™ื

ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ื”ื‘ื˜ื™ื—ื•ืช ืฆืจื™ืš ืงื•ื“ื ื›ืœ ืœื”ื‘ื™ืŸ ืื™ืš ื”ืžืคืชื—ื™ื ืื•ืกืคื™ื ื•ืžืฉืชืคื™ื ืืช ื”ื ืชื•ื ื™ื ืฉืœืš. ื ื•ื”ืœื™ ืคืจื˜ื™ื•ืช ื”ื ืชื•ื ื™ื ื•ืื‘ื˜ื—ืช ื”ื ืชื•ื ื™ื ืขืฉื•ื™ื™ื ืœื”ืฉืชื ื•ืช ื‘ื”ืชืื ืœืฉื™ืžื•ืฉ, ืœืื–ื•ืจ ื•ืœื’ื™ืœ ื”ืžืฉืชืžืฉ. ื”ืžืคืชื— ืกื™ืคืง ืืช ื”ืžื™ื“ืข ื”ื–ื” ื•ื”ื•ื ืขืฉื•ื™ ืœืขื“ื›ืŸ ืื•ืชื• ืžื“ื™ ืคืขื.

ืชืžื™ื›ื” ื‘ืืคืœื™ืงืฆื™ื”

ืžื™ื“ืข ืขืœ ืžืคืชื—ื™ ื”ืืคืœื™ืงืฆื™ื”
IPACEMAKER SRL
ipacemakerinfo@gmail.com
VIA ZURIGO 28 20147 MILANO Italy
+39 344 193 5272